Breaking News

WuXi STA Passes First EMA Drug Pre-Approval Inspection at Wuxi City Site

The Wuxi City site will start to provide commercial drug product manufacturing service of an innovative medicine for the European market.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

WuXi STA, a subsidiary of WuXi AppTec, has successfully passed its first pre-approval inspection (PAI) and received the GMP Compliance Certificate from the European Medicines Agency (EMA) for its drug product facility in Wuxi City, China     The PAI focused on the drug product manufacturing of an innovative drug for one of WuXi STA’s partners. During a 5-day remote inspection, the inspector assessed the compliance of the manufacturing operations against the EU Guideline to Good Manufacturing P...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters